Developed by Syracuse University researchers, the approach combines specific binders with a common nanopore to detect various types of proteins.
The technology uses DNA nanostructures paired with nanopore sensing to potentially detect hundreds of targets per sample.
Stanford researchers said the cost of their approach is in line with Illumina sequencing but did not share data on error rate and other benchmarks at this time.
Plans are underway to make the test, which provides results in five minutes, available clinically in both single and multiplex formats.
Clear Labs, Integrated DNA Technologies Expand Partnership to Include COVID-19 Testing
The collaboration builds on an oligonucleotide supply agreement the partners signed in 2019 for Clear Labs' nanopore sequencing-based food safety testing.